S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:ATRS

Antares Pharma News Headlines

$4.15
+0.09 (+2.22 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.89
Now: $4.15
$4.16
50-Day Range
$4.06
MA: $4.49
$4.85
52-Week Range
$1.60
Now: $4.15
$5.07
Volume2.16 million shs
Average Volume1.50 million shs
Market Capitalization$691.69 million
P/E Ratio69.18
Dividend YieldN/A
Beta1.44

Headlines

Antares Pharma (NASDAQ ATRS) News Headlines Today

Source:
SourceHeadline
Piper Sandler Analysts Decrease Earnings Estimates for Antares Pharma, Inc. (NASDAQ:ATRS)Piper Sandler Analysts Decrease Earnings Estimates for Antares Pharma, Inc. (NASDAQ:ATRS)
americanbankingnews.com - March 4 at 8:27 AM
Antares Pharma (NASDAQ:ATRS) Issues Quarterly  Earnings ResultsAntares Pharma (NASDAQ:ATRS) Issues Quarterly Earnings Results
americanbankingnews.com - March 3 at 12:48 PM
Antares Pharma (NASDAQ:ATRS)  Shares Down 9.8% Antares Pharma (NASDAQ:ATRS) Shares Down 9.8%
americanbankingnews.com - March 2 at 7:44 PM
Recap: Antares Pharma Q4 EarningsRecap: Antares Pharma Q4 Earnings
finance.yahoo.com - March 2 at 12:49 PM
Antares Pharma (ATRS) Q4 Earnings Lag EstimatesAntares Pharma (ATRS) Q4 Earnings Lag Estimates
finance.yahoo.com - March 2 at 12:49 PM
Antares Pharma (NASDAQ:ATRS) Trading Up 5.9%Antares Pharma (NASDAQ:ATRS) Trading Up 5.9%
americanbankingnews.com - March 1 at 9:00 PM
Antares Pharmas Earnings: A PreviewAntares Pharma's Earnings: A Preview
finance.yahoo.com - March 1 at 3:08 PM
Is Antares Pharma (NASDAQ:ATRS) Using Too Much Debt?Is Antares Pharma (NASDAQ:ATRS) Using Too Much Debt?
finance.yahoo.com - February 25 at 7:33 AM
Antares Pharma (ATRS) to Release Earnings on TuesdayAntares Pharma (ATRS) to Release Earnings on Tuesday
americanbankingnews.com - February 24 at 9:17 AM
Antares Pharma (NASDAQ:ATRS) Stock Price Down 7.1%Antares Pharma (NASDAQ:ATRS) Stock Price Down 7.1%
americanbankingnews.com - February 23 at 7:22 PM
Leonard S. Jacob Sells 15,321 Shares of Antares Pharma, Inc. (NASDAQ:ATRS) StockLeonard S. Jacob Sells 15,321 Shares of Antares Pharma, Inc. (NASDAQ:ATRS) Stock
americanbankingnews.com - February 20 at 12:58 AM
Insider Selling: Antares Pharma, Inc. (NASDAQ:ATRS) CEO Sells 491,960 Shares of StockInsider Selling: Antares Pharma, Inc. (NASDAQ:ATRS) CEO Sells 491,960 Shares of Stock
americanbankingnews.com - February 20 at 12:12 AM
Antares Pharma, Inc. (NASDAQ:ATRS) EVP Peter J. Graham Sells 45,000 SharesAntares Pharma, Inc. (NASDAQ:ATRS) EVP Peter J. Graham Sells 45,000 Shares
americanbankingnews.com - February 20 at 12:12 AM
Antares Pharma (NASDAQ:ATRS) Reaches New 12-Month High at $4.88Antares Pharma (NASDAQ:ATRS) Reaches New 12-Month High at $4.88
americanbankingnews.com - February 18 at 11:21 AM
Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare ConferenceAntares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference
feeds.benzinga.com - February 17 at 9:12 AM
Antares Pharma, Inc. (NASDAQ:ATRS) Director Thomas J. Garrity Sells 50,000 SharesAntares Pharma, Inc. (NASDAQ:ATRS) Director Thomas J. Garrity Sells 50,000 Shares
americanbankingnews.com - February 12 at 9:38 PM
Antares Pharma, Inc. (NASDAQ:ATRS) CEO Sells $34,570.50 in StockAntares Pharma, Inc. (NASDAQ:ATRS) CEO Sells $34,570.50 in Stock
americanbankingnews.com - February 11 at 12:46 AM
Robert F. Apple Sells 33,574 Shares of Antares Pharma, Inc. (NASDAQ:ATRS) StockRobert F. Apple Sells 33,574 Shares of Antares Pharma, Inc. (NASDAQ:ATRS) Stock
americanbankingnews.com - February 11 at 12:46 AM
Is Antares Pharma, Inc.s(NASDAQ:ATRS) Recent Stock Performance Tethered To Its Strong Fundamentals?Is Antares Pharma, Inc.'s(NASDAQ:ATRS) Recent Stock Performance Tethered To Its Strong Fundamentals?
finance.yahoo.com - January 26 at 7:18 AM
Worldwide Needle Free Diabetes Care Industry to 2025 - Players Include Akra Dermojet, Antares Pharma & Bioject Medical Technologies Among OthersWorldwide Needle Free Diabetes Care Industry to 2025 - Players Include Akra Dermojet, Antares Pharma & Bioject Medical Technologies Among Others
prnewswire.com - January 25 at 10:57 AM
Antares Pharma trades higher on revenue guidance for FY 2021Antares Pharma trades higher on revenue guidance for FY 2021
seekingalpha.com - January 11 at 1:52 PM
What Is Antares Pharma, Inc.s (NASDAQ:ATRS) Share Price Doing?What Is Antares Pharma, Inc.'s (NASDAQ:ATRS) Share Price Doing?
finance.yahoo.com - December 27 at 9:36 AM
Is ATRS A Good Stock To Buy Now?Is ATRS A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 1:10 PM
Will the Promising Trends At Antares Pharma (NASDAQ:ATRS) Continue?Will the Promising Trends At Antares Pharma (NASDAQ:ATRS) Continue?
finance.yahoo.com - December 1 at 7:21 AM
Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceAntares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 23 at 5:26 PM
Antares Pharma to Present at the Jefferies Virtual London Healthcare ConferenceAntares Pharma to Present at the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 6:41 PM
Antares Pharma Inc (ATRS) Q3 2020 Earnings Call TranscriptAntares Pharma Inc (ATRS) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 5 at 11:11 PM
Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call TranscriptAntares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 1:10 PM
Antares Pharma (ATRS) Q3 Earnings Match EstimatesAntares Pharma (ATRS) Q3 Earnings Match Estimates
finance.yahoo.com - November 5 at 1:10 PM
How Much Of Antares Pharma, Inc. (NASDAQ:ATRS) Do Insiders Own?How Much Of Antares Pharma, Inc. (NASDAQ:ATRS) Do Insiders Own?
finance.yahoo.com - November 5 at 8:09 AM
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating ResultsAntares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
finance.yahoo.com - November 5 at 8:09 AM
Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseAntares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - October 29 at 2:00 PM
Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S.Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S.
seekingalpha.com - October 1 at 12:18 PM
Needle Free Injection Systems Market 2020 Global Outlook – Antares Pharma, Endo International, Pharmajet, Bioject Medical TechnologiesNeedle Free Injection Systems Market 2020 Global Outlook – Antares Pharma, Endo International, Pharmajet, Bioject Medical Technologies
marketwatch.com - September 22 at 3:47 AM
Antares Pharma (NASDAQ:ATRS) Stock Rating Reaffirmed by Raymond JamesAntares Pharma (NASDAQ:ATRS) Stock Rating Reaffirmed by Raymond James
americanbankingnews.com - September 15 at 6:16 AM
Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment ConferenceAntares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
finance.yahoo.com - September 8 at 10:11 AM
These 4 Measures Indicate That Antares Pharma (NASDAQ:ATRS) Is Using Debt Reasonably WellThese 4 Measures Indicate That Antares Pharma (NASDAQ:ATRS) Is Using Debt Reasonably Well
finance.yahoo.com - September 6 at 2:32 PM
Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor RelationsAntares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
finance.yahoo.com - August 10 at 9:33 AM
A Quick Analysis On Antares Pharmas (NASDAQ:ATRS) CEO CompensationA Quick Analysis On Antares Pharma's (NASDAQ:ATRS) CEO Compensation
finance.yahoo.com - August 7 at 10:39 AM
A Quick Analysis On Antares Pharma's (NASDAQ:ATRS) CEO CompensationA Quick Analysis On Antares Pharma's (NASDAQ:ATRS) CEO Compensation
finance.yahoo.com - August 7 at 10:39 AM
Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call TranscriptAntares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 6 at 6:07 PM
Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue GuidanceAntares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance
finance.yahoo.com - August 6 at 8:06 AM
Why Antares Pharmas Stock Is Trading Higher TodayWhy Antares Pharma's Stock Is Trading Higher Today
benzinga.com - August 3 at 7:07 PM
Did Hedge Funds Make The Right Call On Antares Pharma Inc (ATRS)?Did Hedge Funds Make The Right Call On Antares Pharma Inc (ATRS)?
finance.yahoo.com - August 3 at 1:57 PM
Antares Pharma inks distribution deal for Xyosted in Gulf countriesAntares Pharma inks distribution deal for Xyosted in Gulf countries
seekingalpha.com - August 3 at 8:30 AM
Antares Pharma to Report Second Quarter 2020 Operating and Financial ResultsAntares Pharma to Report Second Quarter 2020 Operating and Financial Results
finance.yahoo.com - July 30 at 8:21 AM
First Commercial Product Using Antares Pharma’s  Multi-Dose Pen Platform Launches in EuropeFirst Commercial Product Using Antares Pharma’s Multi-Dose Pen Platform Launches in Europe
finance.yahoo.com - July 21 at 8:08 AM
Antares Continues To Quietly Grow RevenueAntares Continues To Quietly Grow Revenue
seekingalpha.com - July 15 at 7:40 AM
Antares Pharma to Present at the Raymond James Human Health Innovation ConferenceAntares Pharma to Present at the Raymond James Human Health Innovation Conference
finance.yahoo.com - June 11 at 8:00 AM
Why Is This Fast-Growing Biotech So Undervalued?Why Is This Fast-Growing Biotech So Undervalued?
finance.yahoo.com - May 28 at 8:39 AM
This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.